2022 - Research.com Immunology in Belgium Leader Award
Guy Brusselle spends much of his time researching Immunology, COPD, Asthma, Internal medicine and Lung. His work carried out in the field of Immunology brings together such families of science as Genome-wide association study and Pathology. His studies in COPD integrate themes in fields like Respiratory disease, Cohort study, Antibody, Spirometry and Systemic inflammation.
His Asthma research incorporates elements of Placebo, Placebo-controlled study, Allergy and Intensive care medicine. The various areas that Guy Brusselle examines in his Internal medicine study include Cross-sectional study and Physical therapy. His study looks at the relationship between Physical therapy and topics such as Prospective cohort study, which overlap with Cohort.
His main research concerns Internal medicine, COPD, Immunology, Asthma and Rotterdam Study. Guy Brusselle has included themes like Gastroenterology and Cardiology in his Internal medicine study. His research integrates issues of Disease, Pathology, Intensive care medicine, Physical therapy and Spirometry in his study of COPD.
His studies deal with areas such as Bronchoalveolar lavage and Lung as well as Immunology. His Asthma research incorporates themes from Corticosteroid, Placebo, Pediatrics and Allergy. His Rotterdam Study study combines topics from a wide range of disciplines, such as Proportional hazards model and Hazard ratio.
His primary areas of study are Internal medicine, Asthma, COPD, Rotterdam Study and Exacerbation. His study on Cohort, FEV1/FVC ratio and Corticosteroid is often connected to In patient as part of broader study in Internal medicine. His Asthma research also works with subjects such as
His COPD study incorporates themes from Vital capacity, Immunology, Pathogenesis, Disease and Atrial fibrillation. Guy Brusselle interconnects Inflammation and Lung in the investigation of issues within Pathogenesis. His research in Rotterdam Study intersects with topics in Hazard ratio, Proportional hazards model, Spirometry and Cardiology.
Guy Brusselle mainly investigates Internal medicine, Asthma, COPD, Exacerbation and Randomized controlled trial. Internal medicine is closely attributed to Placebo in his work. His Asthma research is multidisciplinary, incorporating elements of mHealth, Allergy and Intensive care medicine.
His COPD research is multidisciplinary, relying on both Genome-wide association study, Immunology, FEV1/FVC ratio, Lung and Disease. His work in the fields of Immunology, such as Inflammation, intersects with other areas such as Betacoronavirus. His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Observational study, Clinical trial and Fluticasone propionate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle.
The New England Journal of Medicine (2014)
The Rotterdam Study: Objectives and design update
Albert Hofman;Guy G. O. Brusselle;Sarwa Darwish Murad;Cornelia M. van Duijn.
European Journal of Epidemiology (2007)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro;James Zangrilli;Michael E Wechsler;Eric D Bateman.
The Lancet Respiratory Medicine (2015)
New insights into the immunology of chronic obstructive pulmonary disease
Guy G Brusselle;Guy F Joos;Ken R Bracke.
The Lancet (2011)
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function
Dana B. Hancock;Mark Eijgelsheim;Jemma B. Wilk;Sina A. Gharib.
Nature Genetics (2010)
Attenuation of allergic airway inflammation in IL-4 deficient mice
G. G. Brusselle;J. C. Kips;J. H. Tavernier;J. G. Van Der Heyden.
Clinical & Experimental Allergy (1994)
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme.
The Journal of Allergy and Clinical Immunology (2012)
Treatable traits: toward precision medicine of chronic airway diseases.
Alvar Agusti;Elisabeth Bel;Mike Thomas;Claus Vogelmeier.
European Respiratory Journal (2016)
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema
Ingel K Demedts;Tine Demoor;Ken R Bracke;Guy F Joos.
Respiratory Research (2006)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
Klaus F. Rabe;Parameswaran Nair;Guy Brusselle;Jorge F. Maspero.
The New England Journal of Medicine (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: